Stock data
Gossamer Bio, Inc. (GOSS)
Gossamer Bio, Inc. (GOSS) reported revenue of US$48.47M and net income of -US$170.37M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$48.47M | — | -US$170.73M | -US$170.37M | — |
| 2024 | US$114.70M | — | -US$59.92M | -US$56.53M | — |
| 2023 | US$0.00M | — | -US$183.76M | -US$179.82M | — |
| 2022 | US$0.00M | — | -US$218.59M | -US$229.38M | — |
| 2021 | — | — | -US$216.12M | -US$234.00M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$9.24M | US$16.90M | — |
| 2026-03-31 | US$16.95M | -US$46.66M | — |
| 2025-12-31 | US$13.80M | -US$47.24M | — |
| 2025-09-30 | US$13.29M | -US$48.22M | — |
| 2025-06-30 | US$11.49M | -US$38.27M | — |
| 2025-03-31 | US$9.89M | -US$36.64M | — |
| 2024-12-31 | US$9.38M | -US$33.03M | — |
| 2024-09-30 | US$9.48M | -US$30.80M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.